IFNG and B-cell chronic lymphocytic leukemia: For this purpose, CLL cells from three different patients with CLL, were treated with 0.1% DMSO (vehicle control), 100 ng/mL IFNγ, 10 nM PMA/1 μM ionomycin, and 100 ng/mL sCD40L for 1 h.